SOLID DOSAGE FORM OF ANTIDIABETIC DRUG BASED ON N-SUBSTITUTED DERIVATIVE AMRINONE - KINASE INHIBITOR OF GLUCOGEN SYNTHASE

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, specifically to agents for the treatment of type II diabetes. Essence of the invention consists in the creation of a solid dosage form of an antidiabetic drug based on the N-substituted derivative amrinone-kinase inhibitor of glycogen synthase 4-methoxy-N-(6-oxo-1,6-dihydro-3,4'-bipyridine-5-yl)benzamide 1, containing active substance 1 and excipients in the ratio indicated in the claims. ; .;EFFECT: new solid dosage form expands the range of antidiabetic agents.;13 cl, 4 ex